Rocephine + Lidocaine IM 1 g + 35 mg/3,5 ml inj. sol. (pwdr. + solv.) i.m. vial + amp.

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Ceftriaxone Disodium 1193 mg - Eq. Ceftriaxone 1 g (powder); Lidocaine Hydrochloride 10 mg/ml (solvent)

MAH:

Roche SA-NV

ATC_code:

J01DD04

INN:

Ceftriaxone (Di)Sodium; Lidocaine Hydrochloride

dosage:

1 g + 35 mg/3,5 ml

pharmaceutical_form:

Powder and solvent for solution for injection

composition:

Ceftriaxone (Di)Sodium 1193 mg; Lidocaine Hydrochloride 10 mg/ml

administration_route:

Intramuscular use

therapeutic_area:

Ceftriaxone

leaflet_short:

CTI code: 129927-02 - Pack size: 5 x (1 g + 3.5 ml) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 129927-01 - Pack size: 1 g + 3.5 ml - Commercialisation status: YES - FMD code: 07613326003391 - CNK code: 0800912 - Delivery mode: Medical prescription

authorization_status:

Commercialised: Yes

authorization_date:

1984-12-05